General Information of the Compound
| Compound ID |
CP0249330
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(10S,12Z)-6-hydroxy-4-methoxy-10-methyl-9-oxatricyclo[15.3.1.02,7]henicosa-1(20),2(7),3,5,12,17(21),18-heptaene-8,14-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H22O5
|
||||||||||||||||||
| Molecular Weight |
366.413
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(O)c2c(c1)-c1cccc(CCC(=O)\C=C/C[C@H](C)OC2=O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H22O5/c1-14-5-3-8-17(23)10-9-15-6-4-7-16(11-15)19-12-18(26-2)13-20(24)21(19)22(25)27-14/h3-4,6-8,11-14,24H,5,9-10H2,1-2H3/b8-3-/t14-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WAYBUMGYWVVITR-FCIQKIPGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Protein ID: PT00925, Vascular endothelial growth factor receptor 3